Neil Desai - Apr 6, 2023 Form 4 Insider Report for Aadi Bioscience, Inc. (AADI)

Role
Executive Chairman, Director, 10%+ Owner
Signature
/s/ Stephen Rodin, as Attorney-in-Fact
Stock symbol
AADI
Transactions as of
Apr 6, 2023
Transactions value $
-$86,616
Form type
4
Date filed
4/6/2023, 08:45 PM
Previous filing
Apr 5, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AADI Common Stock Sale -$86.6K -12.2K -0.65% $7.09 1.87M Apr 6, 2023 See footnote F1, F2, F3
holding AADI Common Stock 640K Apr 6, 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 12,212 shares sold in the price range of $7.00 to $7.23 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.
F4 Shares held by Anishka Irrevocable 2016 Trust dated October 19, 2016 (the "Irrevocable Trust"). The Reporting Person disclaims beneficial ownership of the shares held by the Irrevocable Trust except to the extent of any pecuniary interest therein, and this filing shall not be deemed an admission that Dr. Desai is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.